Overview
Lakshminarayanan Nandagopal is a Hematologist and an Oncologist in Fredericksburg, Virginia. Dr. Nandagopal is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Thrombocytopenia, Familial Prostate Cancer, Prostate Cancer, and Neuroendocrine Tumor.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- POS
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4501 Empire Ct, Fredericksburg, VA 22408
Additional Areas of Focus
Dr. Nandagopal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mgmc LLC
Geoffrey Gibney is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Gibney is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Sinus Cancer, and Olfactory Neuroblastoma.
Medstar Medical Group Ii LLC
Michael Atkins is an Oncologist in Washington, Washington, D.c.. Dr. Atkins is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Nephrectomy.
Mcv Associated Physicians
Andrew Poklepovic is a Hematologist and an Oncologist in Richmond, Virginia. Dr. Poklepovic is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Synovial Sarcoma, Angiosarcoma, Merkel Cell Carcinoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Prostate CancerDr. Nandagopal isAdvanced. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Nandagopal isAdvanced. Learn about Prostate Cancer.
- ThrombocytopeniaDr. Nandagopal isAdvanced. Learn about Thrombocytopenia.
- Experienced
- Acute Myeloblastic Leukemia with MaturationDr. Nandagopal isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Nandagopal isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Nandagopal isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Nandagopal isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Nandagopal isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Nandagopal isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.